Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy.
Moiseenko A, Sinadinos A, Sergijenko A, Pineault K, Saleh A, Nekola K, Strang N, Eleftheraki A, Boyd AC, Davies JC, Gill DR, Hyde SC, McLachlan G, Rath T, Rothe M, Schambach A, Hobbie S, Schuler M, Maier U, Thomas MJ, Mennerich D, Schmidt M, Griesenbach U, Alton EWFW, Kreuz S.
Moiseenko A, et al. Among authors: rath t.
Eur Respir J. 2024 Nov 21:2301683. doi: 10.1183/13993003.01683-2023. Online ahead of print.
Eur Respir J. 2024.
PMID: 39174284
Free article.